Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: Results from the German DES.DE-Registry

Clinical Research in Cardiology

Volumn 100, Issue 8, 2011, Pages 701-709

  Bauer, Timm ^a   Nienaber, Christoph A ^b   Akin, Ibrahim ^b   Kuck, Karl Heinz ^c   Hochadel, Matthias ^d   Senges, Jochen ^d   Fetsch, Thomas ^e   Tebbe, Ulrich ^f   Willich, Stefan N ^g   Stumpf, Jürgen ^h   Sabin, Georg V ⁱ   Silber, Sigmund ^j   Richardt, Gert ^k  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Institut für Klinisch Kardiovaskuläre Forschung   (Germany)

^f KLINIKUM LIPPE DETMOLD   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h Gemeinschaftspraxis Kardiologie und Angiologie   (Germany)

ⁱ ELISABETH KRANKENHAUS ESSEN   (Germany)

^j Kardiologische Gemeinschaftspraxis und Praxisklinik   (Germany)

^k Segeberger Klinikum   (Germany)

more..

Author keywords

Clinical practice; Drug eluting stents; Off label; Outcome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; PHENPROCOUMON; RAPAMYCIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; BYPASS SURGERY; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DISEASE REGISTRY; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; GERMANY; GRAFT OCCLUSION; HAZARD RATIO; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OFF LABEL DRUG USE; PERCUTANEOUS CORONARY INTERVENTION; PHASE 1 CLINICAL TRIAL; PRESCRIPTION; PROSPECTIVE STUDY; RESUSCITATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURVIVOR; TREATMENT INDICATION;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OFF-LABEL USE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 80051784093     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0301-8     Document Type: Article

References (30)

1. MC Morice PW Serruys E Sousa J Fajadet E Ban Hayashi M Perin A Colombo G Schuler P Barragan G Guagliumi F Molnàr R Falotico 2002 A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773 1780 12050336 10.1056/NEJMoa012843 1:CAS:528:DC%2BD38Xkt1Olsbw%3D (Pubitemid 34586912)
2. JW Moses MB Leon JJ Popma PJ Fitzgerard DR Holmes C O'Shaughnessy RP Caputo DJ Kereiakes DO Williams PS Teirstein JL Jaeger RE Kuntz 2003 Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 1315 1323 14523139 10.1056/NEJMoa035071 1:CAS:528:DC%2BD3sXnvVGitrc%3D (Pubitemid 37186209)
3. GW Stone SG Ellis DA Cox J Hermiller C O'Shaughnessy JT Mann M Turco R Caputo P Bergin J Greenberg JJ Popma ME Russell 2004 One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 1942 1947 15078803 10.1161/01.CIR.0000127110. 49192.72 1:CAS:528:DC%2BD2cXjtFOmt74%3D (Pubitemid 38544483)
4. N Beohar CJ Davidson KE Kip L Goodreau HA Vlachos SN Meyers KH Benzuly JD Flaherty MJ Ricciardi CL Bennett DO Williams 2007 Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 1992 2000 17488964 10.1001/jama.297.18.1992 1:CAS:528:DC%2BD2sXltFyks70%3D (Pubitemid 46740351)
5. HK Win AE Caldera K Maresh J Lopez CS Rihal MA Parikh JF Granada S Marulkar D Nassif DJ Cohen NS Kleiman EVENT Registry Investigators 2007 Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2001 2009 17488965 10.1001/jama.297.18.2001 1:CAS:528: DC%2BD2sXltFyks7o%3D (Pubitemid 46740352)
6. RJ Applegate MT Sacrinty MA Kutcher RM Santos SK Gandhi TT Baki WC Little 2008 "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents J Am Coll Cardiol 51 607 614 18261678 10.1016/j.jacc.2007.08.064 (Pubitemid 351193101)
7. BR Brodie T Stuckey W Downey A Humphrey B Bradshaw C Metzger J Hermiller F Krainin S Juk B Cheek P Duffy H Smith J Edmunds J Varanasi CA Simonton STENT (Strategic Transcatheter Evaluation of New Therapies) Group 2008 Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group JACC Cardiovasc Interv 1 405 414 19463338 10.1016/j.jcin.2008.06.005
8. J Carlsson SK James J Lindbäck F Scherstén T Nilsson U Stenestrand B Lagerqvist SCAAR (Swedish Coronary Angiography and Angioplasty Registry) Study Group 2009 Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria J Am Coll Cardiol 53 1389 1398 19371822 10.1016/j.jacc.2008.09.067 1:CAS:528:DC%2BD1MXkslGqtLg%3D
9. JP Girod SR Mulukutla OC Marroquin 2008 Off-label use of stents: bare-metal versus drug-eluting stents Expert Rev Cardiovasc Ther 6 1095 1106 18793112 10.1586/14779072.6.8.1095 1:CAS:528:DC%2BD1cXhtFartb7N
10. CL Grines 2008 Off-label use of drug-eluting stents putting it in perspective J Am Coll Cardiol 51 615 617 18261679 10.1016/j.jacc.2007.10.028 (Pubitemid 351186866)
11. KJ Harjai P Orshaw J Boura D Sporn 2009 Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings Am J Cardiol 103 1537 1545 19463512 10.1016/j.amjcard.2009. 02.017 1:CAS:528:DC%2BD1MXmtlOltrs%3D
12. KJ Harjai P Orshaw C Shenoy S Acharji D Sporn A Aboufares D Stapleton 2008 Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study) J Interv Cardiol 21 315 324 18754967 10.1111/j.1540-8183.2008.00380.x (Pubitemid 352033300)
13. DT Ko M Chiu H Guo PC Austin R Goeree E Cohen M Labinaz JV Tu 2009 Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications J Am Coll Cardiol 53 1773 1782 19422984 10.1016/j.jacc.2009.01.059
14. OC Marroquin F Selzer SR Mulukutla DO Williams HA Vlachos RL Wilensky JF Tanguay EM Holper JD Abbott JS Lee C Smith WD Anderson SF Kelsey KE Kip 2008 A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 342 352 18216354 10.1056/NEJMoa0706258 1:CAS:528: DC%2BD1cXhtFCjsrs%3D (Pubitemid 351159233)
15. A Qasim J Cosgrave A Latib A Colombo 2007 Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications Am J Cardiol 100 1619 1624 18036358 10.1016/j.amjcard.2007.07.013 1:CAS:528: DC%2BD2sXhtlCru7bK (Pubitemid 350122326)
16. DR Ramsdale A Rao O Asghar KA Ramsdale E McKay 2008 Late outcomes after drug-eluting stent implantation in "real-world" clinical practice J Invasive Cardiol 20 493 500 18829991
17. SV Rao RE Shaw RG Brindis LW Klein WS Weintraub ED Peterson American College of Cardiology National Cardiovascular Data Registry 2006 On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR]) Am J Cardiol 97 1478 1481 16679087 10.1016/j.amjcard.2005.11.081 1:CAS:528:DC%2BD28XksVOnt7c%3D
18. P Roy AN Buch A Javaid T Okabe V Raya TL Pinto Slottow DH Steinberg K Smith Z Xue N Gevorkian LF Satler KM Kent WO Suddath AD Pichard J Lindsay R Waksman 2008 Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention Am J Cardiol 101 293 299 18237587 10.1016/j.amjcard.2007.08.048 1:CAS:528:DC%2BD1cXhsVSms70%3D (Pubitemid 351162956)
19. Akin I, Bufe A, Schneider S, Reinecke H, Eckardt L, Richardt G, Burska D, Senges J, Kuck KH, Nienaber CA (2010) Clinical outcomes in diabetic and non-diabetic patients with drug-eluting stents: results from the first phase of the prospective multicenter German DES.DE registry. Clin Res Cardiol
20. CA Nienaber I Akin S Schneider J Senges T Fetsch U Tebbe S Willich J Stumpf GV Sabin S Silber G Richardt KH Kuck 2009 Clinical Outcomes after Sirolimus-eluting, Paclitaxel-eluting and Bare-metal Stents (From the First Phase of the Prospective Multicenter German DES.DE Registry) Am J Cardiol 104 1362 1369 19892051 10.1016/j.amjcard.2009.06.058 1:CAS:528:DC%2BD1MXhtlyjt77I
21. S Silber P Albertson FF Aviles PG Camici A Colombo C Hamm E Jorgensen J Marco JE Nordrehaug JE Ruzyllo P Urban GW Stone W Wijns 2005 Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of cardiology Eur Heart J 26 804 847 15769784 10.1093/eurheartj/ehi564
22. Flynn MR, Barrett C, Cosío FG, Gitt AK, Wallentin L, Kearney P, Lonergan M, Shelley E, Simoons ML. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice (2005) Eur Heart J 26:308-313 (Pubitemid 40227433)
23. Mudra H, Bode C, Grube E, de Haan F, Levenson B, Schuler G, Silber S; Vorstand der Deutschen Gesellschaft für Kardiologie- Herz- und Kreislaufforschung; Auftrag der Kommission für Klinische Kardiologie (2004) Position paper on the use of drug eluting stents in coronary heart disease Z Kardiol 93:416-422
24. DE Cutlip S Windecker R Mehran A Boam DJ Cohen GA van Es PE Steg MA Morel L Mauri P Vranckx E McFadden A Lansky M Hannon MW Krucoff PW Serruys Academic Research Consortium 2007 Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2344 2351 17470709 10.1161/CIRCULATIONAHA.106.685313 (Pubitemid 46685903)
25. Silber S, Borggrefe M, Böhm M, Hoffmeister HM, Dietz R, Ertl G, Heusch G (2008) Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK. Clin Res Cardiol 97:548-563
26. R Zahn CW Hamm S Schneider U Zeymer G Richardt M Kelm B Levenson T Bonzel U Tebbe G Sabin CA Nienaber T Pfannebecker J Senges German Cypher Stent Registry 2007 The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry Clin Res Cardiol 96 548 556 17534566 10.1007/s00392-007-0531-y 1:CAS:528:DC%2BD2sXhtVSrurrP (Pubitemid 47106499)
27. AA Bavry DJ Kumbhani TJ Helton PP Borek GR Mood DL Bhatt 2006 Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials Am J Med 119 1056 1061 17145250 10.1016/j.amjmed.2006.01.023 1:CAS:528:DC%2BD28Xht1Kks7bK (Pubitemid 44826931)
28. C Stettler S Wandel S Allemann A Kastrati MC Morice A Schömig ME Pfisterer GW Stone MB Leon JS de Lezo JJ Goy SJ Park M Sabaté MJ Suttorp H Kelbaek C Spaulding M Menichelli P Vermeersch MT Dirksen P Cervinka AS Petronio AJ Nordmann P Diem B Meier M Zwahlen S Reichenbach S Trelle S Windecker P Jüni 2007 Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 937 948 17869634 10.1016/S0140-6736(07)61444-5 1:CAS:528:DC%2BD2sXhtVeqsL7E (Pubitemid 47393576)
29. GJ Mishkel AL Moore S Markwell ME Shelton 2008 Correlates of late and very late thrombosis of drug eluting stents Am Heart J 156 141 147 18585509 10.1016/j.ahj.2008.02.012
30. R Hoffmann H Klinker U Adamu M Kelm R Blindt 2009 The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use Clin Res Cardiol 98 549 554 19669824 10.1007/s00392-009-0039-8 1:CAS:528:DC%2BD1MXhtFCgt7jJ